Our Mission: To revolutionize breast cancer therapy with our patented monoclonal antibody for direct immunotherapy and as an antibody drug conjugate..
For-Robin’s mission is to revolutionize breast cancer treatment through targeted treatment with humanized JAA-F11 monoclonal antibody. Our humanized JAA-F11 can be used directly, or since it internalizes, as an antibody drug conjugate. It will kill tumor cells and block metastasis, without causing side effects since its target, TF-Ag, is not on normal cells. JAA-F11 is protected by a U.S. patent and pending patents in Europe, Canada and Japan.